Those impatiently waiting for full marijuana legalization celebrated a recent victory. CBD is legal.
The U.S. Drug Enforcement Agency (DEA) declared cannabidiol (CBD) will no longer be a focus of the Controlled Substances Act (CSA). In other words, CBD is legal, even though it’s derived from the marijuana plant.
It’s a step in the right direction.
“Products and materials that are made from the cannabis plant and which fall outside the CSA definition of marijuana are not controlled under the CSA,” according to a May 22 statement by the DEA. “Such products may accordingly be sold and otherwise distributed throughout the United States without restriction under the CSA or its implementing regulations.”
To fall under the CSA, a substance must possess a potential for addiction and CBD does not, according to the DEA.
“The mere presence of cannabinoids is not itself dispositive as to whether a substance is within the scope of the CSA; the dispositive question is whether the substance falls within the CSA definition of marijuana,” the DEA stated.
The World Health Organization (WHO) backed up the DEA, declaring updated health standards favor CBD’s new status.
“In humans, CBD exhibits no effects indicative of any abuse or dependence potential,” the WHO stated. “CBD is generally well tolerated with a good safety profile. To date, there is no evidence of recreation use of CBD or any public health-related problems.”
With the DEA’s ruling, “products and materials that are made from the cannabis plant and which fall outside the CSA definition of marijuana (such as sterilized seeds, oil or cake made from the seeds, and mature stalks) are not controlled under the Controlled Substance Act,” according to the DEA. “Such products (like CBD) may accordingly be sold and otherwise distributed throughout the United States without restriction under the CSA or its implementing regulations.”